Care After Lymphoma (CALy) trial: A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care

Karen Taylor, Paola Chivers, Caroline Bulsara, David Joske, Max Bulsara, Leanne Monterosso

Research output: Contribution to journalArticle

Abstract

Purpose: Post-treatment follow-up for lymphoma potentially fails to address the supportive care needs of survivors. A nurse-led lymphoma survivorship model of care was developed and tested in a phase II pilot pragmatic randomised controlled trial (RCT). The intervention comprised three face-to-face appointments, delivery of tailored resources and an individualised survivorship care plan and treatment summary (SCPTS), shared with the general practitioner (GP). Method: Three months’ post-treatment completion, eligible lymphoma patients were randomised 1:1 to usual care (control) or usual care plus intervention. Survivorship unmet needs (Short-Form Survivor Unmet Needs Survey), distress (Depression Anxiety Stress Scale 21), adjustment to cancer (Mini-Mental Adjustment to Cancer scale) and self-empowerment (Patient Empowerment Scale) were assessed at baseline, three and six months. Univariate and multivariate analyses examined changes within and between groups at the three time points. A GP evaluation survey sought information on the perceived utility of the SCPTS. Results: Statistical significance was set at 0.05 (2-tailed). Although not statistically significant, by study completion, intervention participants (n = 30), reported less unmet needs (M = 21.41 vs M = 25.72, p =.506), less distress ((M = 13.03 vs M = 15.14, p =.558) and an increase in empowerment (M = 50.21 vs M = 47.21, p =.056) compared with control participants (n = 30). The SCPTS was rated good to very good by a majority of GPs (n = 13, 81%). Conclusions: The nurse-led lymphoma survivorship model of care may be a helpful intervention for lymphoma patients who had completed treatment. Survivors require individualised and tailored support and resources. A tailored SCPTS may promote survivor self-management and increase GP engagement.

Original languageEnglish
Pages (from-to)53-62
Number of pages10
JournalEuropean Journal of Oncology Nursing
Volume40
DOIs
Publication statusPublished - 1 Jun 2019

Fingerprint

Lymphoma
Survival Rate
Randomized Controlled Trials
Nurses
Survivors
General Practitioners
Social Adjustment
Therapeutics
Anxiety
Depression
Patient Participation
Self Care
Neoplasms
Appointments and Schedules
Multivariate Analysis

Cite this

@article{644ad125fe7b411985a542aaf8e4912b,
title = "Care After Lymphoma (CALy) trial: A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care",
abstract = "Purpose: Post-treatment follow-up for lymphoma potentially fails to address the supportive care needs of survivors. A nurse-led lymphoma survivorship model of care was developed and tested in a phase II pilot pragmatic randomised controlled trial (RCT). The intervention comprised three face-to-face appointments, delivery of tailored resources and an individualised survivorship care plan and treatment summary (SCPTS), shared with the general practitioner (GP). Method: Three months’ post-treatment completion, eligible lymphoma patients were randomised 1:1 to usual care (control) or usual care plus intervention. Survivorship unmet needs (Short-Form Survivor Unmet Needs Survey), distress (Depression Anxiety Stress Scale 21), adjustment to cancer (Mini-Mental Adjustment to Cancer scale) and self-empowerment (Patient Empowerment Scale) were assessed at baseline, three and six months. Univariate and multivariate analyses examined changes within and between groups at the three time points. A GP evaluation survey sought information on the perceived utility of the SCPTS. Results: Statistical significance was set at 0.05 (2-tailed). Although not statistically significant, by study completion, intervention participants (n = 30), reported less unmet needs (M = 21.41 vs M = 25.72, p =.506), less distress ((M = 13.03 vs M = 15.14, p =.558) and an increase in empowerment (M = 50.21 vs M = 47.21, p =.056) compared with control participants (n = 30). The SCPTS was rated good to very good by a majority of GPs (n = 13, 81{\%}). Conclusions: The nurse-led lymphoma survivorship model of care may be a helpful intervention for lymphoma patients who had completed treatment. Survivors require individualised and tailored support and resources. A tailored SCPTS may promote survivor self-management and increase GP engagement.",
keywords = "Lymphoma, Nurse-led model of care, Randomised controlled trial, Survivorship",
author = "Karen Taylor and Paola Chivers and Caroline Bulsara and David Joske and Max Bulsara and Leanne Monterosso",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.ejon.2019.03.005",
language = "English",
volume = "40",
pages = "53--62",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",
publisher = "Churchill Livingstone",

}

Care After Lymphoma (CALy) trial : A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care. / Taylor, Karen; Chivers, Paola; Bulsara, Caroline; Joske, David; Bulsara, Max; Monterosso, Leanne.

In: European Journal of Oncology Nursing, Vol. 40, 01.06.2019, p. 53-62.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Care After Lymphoma (CALy) trial

T2 - A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care

AU - Taylor, Karen

AU - Chivers, Paola

AU - Bulsara, Caroline

AU - Joske, David

AU - Bulsara, Max

AU - Monterosso, Leanne

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Purpose: Post-treatment follow-up for lymphoma potentially fails to address the supportive care needs of survivors. A nurse-led lymphoma survivorship model of care was developed and tested in a phase II pilot pragmatic randomised controlled trial (RCT). The intervention comprised three face-to-face appointments, delivery of tailored resources and an individualised survivorship care plan and treatment summary (SCPTS), shared with the general practitioner (GP). Method: Three months’ post-treatment completion, eligible lymphoma patients were randomised 1:1 to usual care (control) or usual care plus intervention. Survivorship unmet needs (Short-Form Survivor Unmet Needs Survey), distress (Depression Anxiety Stress Scale 21), adjustment to cancer (Mini-Mental Adjustment to Cancer scale) and self-empowerment (Patient Empowerment Scale) were assessed at baseline, three and six months. Univariate and multivariate analyses examined changes within and between groups at the three time points. A GP evaluation survey sought information on the perceived utility of the SCPTS. Results: Statistical significance was set at 0.05 (2-tailed). Although not statistically significant, by study completion, intervention participants (n = 30), reported less unmet needs (M = 21.41 vs M = 25.72, p =.506), less distress ((M = 13.03 vs M = 15.14, p =.558) and an increase in empowerment (M = 50.21 vs M = 47.21, p =.056) compared with control participants (n = 30). The SCPTS was rated good to very good by a majority of GPs (n = 13, 81%). Conclusions: The nurse-led lymphoma survivorship model of care may be a helpful intervention for lymphoma patients who had completed treatment. Survivors require individualised and tailored support and resources. A tailored SCPTS may promote survivor self-management and increase GP engagement.

AB - Purpose: Post-treatment follow-up for lymphoma potentially fails to address the supportive care needs of survivors. A nurse-led lymphoma survivorship model of care was developed and tested in a phase II pilot pragmatic randomised controlled trial (RCT). The intervention comprised three face-to-face appointments, delivery of tailored resources and an individualised survivorship care plan and treatment summary (SCPTS), shared with the general practitioner (GP). Method: Three months’ post-treatment completion, eligible lymphoma patients were randomised 1:1 to usual care (control) or usual care plus intervention. Survivorship unmet needs (Short-Form Survivor Unmet Needs Survey), distress (Depression Anxiety Stress Scale 21), adjustment to cancer (Mini-Mental Adjustment to Cancer scale) and self-empowerment (Patient Empowerment Scale) were assessed at baseline, three and six months. Univariate and multivariate analyses examined changes within and between groups at the three time points. A GP evaluation survey sought information on the perceived utility of the SCPTS. Results: Statistical significance was set at 0.05 (2-tailed). Although not statistically significant, by study completion, intervention participants (n = 30), reported less unmet needs (M = 21.41 vs M = 25.72, p =.506), less distress ((M = 13.03 vs M = 15.14, p =.558) and an increase in empowerment (M = 50.21 vs M = 47.21, p =.056) compared with control participants (n = 30). The SCPTS was rated good to very good by a majority of GPs (n = 13, 81%). Conclusions: The nurse-led lymphoma survivorship model of care may be a helpful intervention for lymphoma patients who had completed treatment. Survivors require individualised and tailored support and resources. A tailored SCPTS may promote survivor self-management and increase GP engagement.

KW - Lymphoma

KW - Nurse-led model of care

KW - Randomised controlled trial

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=85063859791&partnerID=8YFLogxK

U2 - 10.1016/j.ejon.2019.03.005

DO - 10.1016/j.ejon.2019.03.005

M3 - Article

VL - 40

SP - 53

EP - 62

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

ER -